Hanson & Doremus Investment Management increased its stake in Stericycle, Inc. (NASDAQ:SRCL) by 72.7% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 20,230 shares of the business services provider’s stock after buying an additional 8,513 shares during the period. Hanson & Doremus Investment Management’s holdings in Stericycle were worth $1,449,000 as of its most recent SEC filing.
A number of other hedge funds also recently bought and sold shares of the stock. Cipher Capital LP purchased a new position in Stericycle during the 2nd quarter valued at about $2,600,000. Stevens Capital Management LP purchased a new position in Stericycle during the 2nd quarter valued at about $6,240,000. Janus Henderson Group PLC boosted its holdings in shares of Stericycle by 31.4% in the 2nd quarter. Janus Henderson Group PLC now owns 16,847 shares of the business services provider’s stock valued at $1,286,000 after buying an additional 4,021 shares in the last quarter. FNY Managed Accounts LLC bought a new stake in shares of Stericycle in the 2nd quarter valued at about $507,000. Finally, Zurcher Kantonalbank Zurich Cantonalbank boosted its holdings in shares of Stericycle by 39.4% in the 2nd quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 202,613 shares of the business services provider’s stock valued at $15,463,000 after buying an additional 57,314 shares in the last quarter. 94.19% of the stock is currently owned by institutional investors.
Stericycle, Inc. (NASDAQ:SRCL) traded up $0.04 during trading on Tuesday, hitting $64.06. 827,100 shares of the stock were exchanged, compared to its average volume of 818,588. Stericycle, Inc. has a fifty-two week low of $61.62 and a fifty-two week high of $88.00. The stock has a market capitalization of $5,465.57, a price-to-earnings ratio of 14.75, a price-to-earnings-growth ratio of 1.75 and a beta of 0.19. The company has a debt-to-equity ratio of 0.93, a current ratio of 0.82 and a quick ratio of 0.82.
Stericycle (NASDAQ:SRCL) last released its earnings results on Wednesday, November 8th. The business services provider reported $1.10 earnings per share (EPS) for the quarter, missing the Zacks’ consensus estimate of $1.14 by ($0.04). The business had revenue of $883.00 million for the quarter, compared to analysts’ expectations of $896.81 million. Stericycle had a positive return on equity of 13.93% and a negative net margin of 0.79%. Stericycle’s quarterly revenue was down .8% compared to the same quarter last year. During the same period in the previous year, the company earned $1.24 EPS. equities analysts expect that Stericycle, Inc. will post 4.49 EPS for the current fiscal year.
A number of analysts have recently weighed in on the stock. Royal Bank Of Canada lowered their price target on shares of Stericycle from $74.00 to $67.00 and set an “underperform” rating on the stock in a report on Thursday, November 9th. William Blair reiterated an “ourperform” rating on shares of Stericycle in a research note on Thursday, September 14th. Barclays PLC reiterated an “overweight” rating and issued a $100.00 target price on shares of Stericycle in a research note on Wednesday, August 9th. BMO Capital Markets lowered their target price on shares of Stericycle from $74.00 to $62.00 and set a “market perform” rating for the company in a research note on Friday. Finally, BidaskClub upgraded shares of Stericycle from a “strong sell” rating to a “sell” rating in a research note on Monday, July 24th. Four analysts have rated the stock with a sell rating, four have assigned a hold rating and six have given a buy rating to the company. The stock currently has an average rating of “Hold” and a consensus target price of $77.17.
In other Stericycle news, Director Mark C. Miller sold 19,753 shares of the company’s stock in a transaction dated Monday, October 30th. The shares were sold at an average price of $70.52, for a total value of $1,392,981.56. Following the transaction, the director now owns 205,576 shares of the company’s stock, valued at $14,497,219.52. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Insiders own 3.30% of the company’s stock.
Stericycle Company Profile
Stericycle, Inc is a business-to-business services provider. The Company focuses on regulated and compliance solutions for healthcare, retail, and commercial businesses. The Company’s segments include Domestic and Canada Regulated Waste and Compliance Services (RCS), Domestic Communication and Related Services (CRS), International RCS and All other.
Receive News & Ratings for Stericycle Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stericycle Inc. and related companies with MarketBeat.com's FREE daily email newsletter.